Gunale B, Farinola N, Yeolekar L, Shrivastava S, et al. A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults. Vaccine 2023 Jul 31:S0264-410X(23)00876-9. doi: 10.1016/j.vaccine.2023.
PMID: 37532611